A recent Japanese cohort study of 3380 premenopausal women with hormone receptor-positive BC found that those with a BMI 25 kg/m 2 (overweight or obese) had significantly worse BC-specific survival compared to women with normal or low BMI
June 30th, 2025: Federal Judge Upholds FDA Ban on Compounded Versions of Ozempic and Wegovy U.S
3a), suggesting no critical contribution of changes in IHL for nonweight-loss remission
Avoiding an unpleasant trade-off Right now, older adults face an unpleasant trade-off: lose weight and improve your cardiovascular health, but perhaps accelerate your decline
And frankly, even if you asked your doctor or nurse what the price is, they probably wouldn't know
Participants remained on their previous antidiabetic drug regimen in addition to IDegLira, insulin degludec, or liraglutide randomized in a 2:1:1 ratio, respectively